PMID: 29851318Jun 1, 2018Paper

Dyslipidemia management in patients with type 1 diabetes

Revue médicale suisse
Stéphanie Andrade LopesGiacomo Gastaldi

Abstract

Cardiovascular diseases are the main cause of mortality in patients with type 1 diabetes (T1DM) despite modern technology and careful metabolic control. The occurrence of dyslipidemia is frequent with T1DM and affects the risk for cardiovascular disease as occur with the occurrence of micro vascular complications. Lifestyle modifications and statin treatment should be regularly evaluated in patients with T1DM. There has been extensive discussion in the media about statin but facts are statins reduce the risk of cardiovascular disease in primary and secondary prevention. In individuals with T1DM, dyslipidemia remains underdiagnosed and insufficiently treated. This article provides a summary of the knowledge about dyslipidemia and T1DM and aims to better identify the patients that should be treated.

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Hiroto Tamaru, Masaharu Ishihara
Current Opinion in Cardiology
Mukul Sharma
JAMA : the Journal of the American Medical Association
Fiona C TaylorShah Ebrahim
Arquivos brasileiros de endocrinologia e metabologia
Alessandra S de Mattos MatheusMarília B Gomes
© 2022 Meta ULC. All rights reserved